ACTIVE

BIOCLI CONSULT

Financial year 2025 · Closed on 31/12/2025

Net result154,8 k €+19,7 %over 1 year
Gross margin205,1 k €+20,0 %over 1 year
Equity3 k €-46,7 %over 1 year

Identity

Source · BCE/KBO

BIOCLI CONSULT is a Private limited company incorporated in 2021. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Jurbise.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0770.990.147
Incorporation
11/07/2021
Legal form
Private limited company
Registered office
Chemin du Prince(EL) 161
7050 Jurbise · WallonieSee on map
Contributed capital
3 000,00 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin205,1 k €170,8 k €146,3 k €126,6 k €57,5 k €
EBITDA203,4 k €169,4 k €145,2 k €125,4 k €57,5 k €
Operating result201,7 k €168 k €144,3 k €125,4 k €57,5 k €
Net result154,8 k €129,3 k €111 k €100,2 k €42,2 k €
Balance sheet
Equity3 k €5,7 k €256,4 k €145,4 k €45,2 k €
Total assets302,8 k €398,9 k €294,1 k €192,9 k €71,1 k €
Cash197,6 k €292,9 k €186,8 k €100,7 k €31,2 k €
Debts299,8 k €393,3 k €37,8 k €47,5 k €25,9 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Stéphane Eeckhoudt

Mandate

Active

Ended mandates

Stéphane Eeckhoudt

Director

Ended

Full financial information

Source · NBB
20252024202320222021
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202211/07/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months6 months
Filing date30/06/202630/06/202529/08/202430/08/202330/06/2022
General meeting07/05/202601/05/202502/05/202404/05/202305/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202507/05/202630/06/2026FrenchPDF
Micro model31/12/202401/05/202530/06/2025FrenchPDF
Micro model31/12/202302/05/202429/08/2024FrenchPDF
Micro model31/12/202204/05/202330/08/2023FrenchPDF
Micro model31/12/202105/05/202230/06/2022FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Stéphane Eeckhoudt

Mandate

Active

Ended mandates

Stéphane Eeckhoudt

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other14/07/2021
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025154,8 k €↑
  2. 2024
    Annual accounts 2024129,3 k €↑
  3. 2023
    Annual accounts 2023111 k €↑
  4. 2022
    Annual accounts 2022100,2 k €↑
  5. 2021
    Annual accounts 202142,2 k €
  6. 11/07/2021
    IncorporationPrivate limited company